or split 8 tetracysteine motif via thiol-arsenic exchange reactions that convert the nonfluorescent 1,2-ethanedithiol (EDT)-bound forms of these dyes into highly fluorescent protein-bound complexes. Despite their utility, however, biarsenicals are plagued by high background signals and cytotoxicity 9, 10 and can be challenging to apply in oxidizing cellular locales. 11, 12 Nontoxic, redoxinsensitive alternatives that combine the convenience and selectivity of a biarsenical with the brightness of a fluorescent protein would be a valuable addition to the cell biologist's "fluorescent toolbox". 2 Here we report that Figure 1A ), a rhodamine-derived bisboronic acid described initially as a monosaccharide sensor, 13 can function as a cellpermeable, turn-on fluorescent sensor for tetraserine motifs in engineered proteins.
It has been known since 1953 that phenyl boronic acid condenses with polyols to form boronate esters 14, 15 and since 1994 that the fluorescence of certain mono-and bis-boronic acid dyes increases upon esterification with simple sugars. 16, 17 The equilibrium stabilities of these complexes are low, however, with K d values in the mM concentration range. We hypothesized that bis-boronic acid dyes would form higher affinity complexes with proteins containing a linear tetraserine motif. RhoBo was chosen as the ideal molecule with which to investigate this hypothesis, as it benefits from a simple synthesis and low monosaccharide affinity and forms boronate esters that emit at wavelengths > 500 nm, 13 a useful range for experiments in live cells.
First, we asked whether RhoBo would form fluorescent complexes with peptides containing 2-4 serine residues separated by a variety of intervening sequences (Figures 1 and 2 ). Each peptide was incubated with RhoBo (17.1 µM) in buffer at 37°C, and the fluorescence emission at 580 nm was monitored as a function of peptide concentration. Under these conditions, peptide 1, containing the sequence SerSer-Pro-Gly-Ser-Ser, formed the highest affinity complex with RhoBo (K app ) 452 ( 106 nM). Titrations with peptides containing two serines rather than four (2) or shorter (3, 4) or longer (5) intervening sequences, or aspartate residues in place of serine (9), led to no detectable fluorescence change. Minimal fluorescence changes were observed with peptides containing threonine (7) or tyrosine (8) Reactions were incubated in 100 mM phosphate buffer (pH 7.4) supplemented with 10% DMSO (37°C, 60 min) and the emission monitored at 580 nm. Each point represents the average of three or more independent trials ( the standard error.
tide aPP containing an N-terminal SSPGSS tag (10) (K d ) 347 ( 234 nM (Figure 2A) ).
Next we examined the affinity of RhoBo for simple monosaccharides, including those prevalent in mammalian oligosaccharide frameworks, 19 to evaluate the extent to which these hydroxyl-rich functionalities might compete with protein tetraserine motifs. Although significant fluorescent changes were observed upon incubation of RhoBo with galactose (Gal), glucose (Glc), fucose (Fuc), mannose (Man), and sialic acid (Sia), these changes occurred at concentrations at least 10 000 times higher than required for peptide 1 ( Figure 2B ). Almost no fluorescence change was observed with N-acetylglucosamine (GlcNac) or with cis-1,2-cyclohexane diol (CHD). We also examined whether RhoBo would form fluorescent complexes with components of a 377-member mammalian glycan microarray (v.3.1; http://www.functionalglycomics.org/). None of the glycans on this array exhibited higher fluorescence than galactose when incubated with RhoBo (84 µM) ( Table S-3) .
To determine whether the RhoBo•1 complex possessed the expected 1:1 stoichiometry, we performed a preparative-scale reaction at a concentration of each reactant that significantly exceeded K app (140 µM), separated the products by HPLC, and determined their masses using MALDI-TOF mass spectrometry. Under these conditions, an equimolar mixture of 1 and RhoBo was converted into a single major product (71% yield) that possessed the expected 1:1 complex mass (expected m/z ) 1696.18, found m/z ) 1695.2; Table S-1). An isomeric product possessing the identical mass (16% yield) was also formed. These isomers possess identical quantum yields ( ) (0.89 ( 0.01) whose value compares well with the quantum yield of fluorescein (0.95) 20 and rhodamine 110 (0.91) 21 and exceeds that of peptide-bound FlAsH (0.5) 5 and RhoBo alone (0.3 ( 0.03).
Finally we evaluated whether RhoBo could circumnavigate the complex, saccharide-rich cell surface to image tetraserine-containing proteins in the cytosol. In contrast to the tetracysteine motif recognized by biarsenicals, which is absent from the human proteome, 22 more than 100 human proteins, including the highly abundant myosin heavy chain, contain an SSPGSS sequence. HeLa cells were first transfected with pDisplay-mCherry, to fluorescently label the plasma membrane, and then treated for 30 min with either 0 or 1 µM RhoBo before imaging using epifluorescence and total internal reflection fluorescence microscopy (TIRFM) ( Figure 3A) . The epifluorescence images show a significant signal at the outer plasma membrane at the mCherry emission maximum (580 nm), irrespective of RhoBo treatment. Only those cells treated with RhoBo, however, show a significant signal when RhoBo was excited specifically using 514 nm light (emission was monitored at 520 nm). In this case fluorescence is observed throughout the cell interior with maximal intensity in perinuclear regions and minimal intensity in the nucleus and outer plasma membrane ( Figure  3B ).
23 RhoBo-treated cells were then imaged using TIRFM, which revealed a significant signal at the mCherry emission maximum (580 nm) but not at the RhoBo emission maximum (520 nm). These images confirm the absence of even low levels of RhoBo emission within the outer 200 nm of the plasma membrane. It is of course possible that RhoBo is associated with constituents of the plasma membrane, but if so, then the complexes formed are not bright. The surprising observation that RhoBo does not fluoresce on the cell surface, coupled with its low toxicity ( Figure S5 ), suggests that current efforts to identify more highly preferred tetraserine motifs will reveal RhoBo as a selective small-molecule tag for proteins on and within living cells.
